Atropine and Shock - a phase IV clinical study of FDA data

Summary:

Shock is reported as a side effect among people who take Atropine (atropine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Diprivan, and have Cardio-respiratory arrest.

The phase IV clinical study analyzes which people have Shock when taking Atropine. It is created by eHealthMe based on reports of 8,649 people who have side effects when taking Atropine from the FDA, and is updated regularly.

What is Atropine?

Atropine has active ingredients of atropine. eHealthMe is studying from 8,693 Atropine users. Check the latest studies of Atropine.

What is Shock?

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin) is found to be associated with 1,224 drugs and 1,753 conditions by eHealthMe. Check the latest studies of Shock.

On Jul, 08, 2026

8,649 people reported to have side effects when taking Atropine.
Among them, 69 people (0.8%) have Shock.

Among these 69 people:

How long have people been on Atropine when they have Shock? *

What is the gender of people who have Shock when taking Atropine? *

female: 47.69 %
male: 52.31 %

What is the age of people who have Shock when taking Atropine? *

What are other drugs people take besides Atropine? *

What are other side effects people have besides Shock? *

Cardiac Arrest: 25 people, 36.23%
Bradycardia (abnormally slow heart action): 19 people, 27.54%
Consciousness - Decreased: 17 people, 24.64%
Hypotension (abnormally low blood pressure): 16 people, 23.19%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 16 people, 23.19%
Cardiogenic Shock (inadequate circulation of blood): 13 people, 18.84%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 13 people, 18.84%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 12 people, 17.39%
Alanine Aminotransferase Increased: 12 people, 17.39%
Partial Seizures (seizures which affect only a part of the brain at onset): 12 people, 17.39%

What are the existing conditions these people have? *

Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 11 people, 15.94%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 10 people, 14.49%
Haemodynamic Instability (disturbances in the blood movement in our body): 9 people, 13.04%
Bradycardia (abnormally slow heart action): 8 people, 11.59%
Heart Disease: 7 people, 10.14%
High Blood Pressure: 7 people, 10.14%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 8.70%
Cardiac Arrest: 6 people, 8.70%
Hypotension (abnormally low blood pressure): 4 people, 5.80%
General Anaesthesia: 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Atropine and have Shock?

- Check whether Shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atropine:

Atropine (8,693 reports)

Shock treatments and more:

Shock (28,534 reports)

Browse all side effects of Atropine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Shock:

Shock (1,224 drugs)

Browse all the conditions that are associated with Shock:

Shock (1,753 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atropine (the active ingredients of Atropine) and Atropine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.